Intézmény

UCLA Health

Los Angeles, Egyesült ÁllamokHonlap

17futó vizsgálat
6lezárt vizsgálat
3528publikáció (OpenAlex)

Futó vizsgálatok

Toboroz
A Study of DS-3939a in Participants With Solid Tumors
NCT07739966· 1/2. fázis· Daiichi Sankyo· Forrás
Toboroz
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
NCT07700979· 3. fázis· Akeso· Forrás
Toboroz
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
NCT07566052· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás
Toboroz
A Gaucher Disease Gene Therapy Trial With FLT201
NCT07223944· 3. fázis· Spur Therapeutics· Forrás
Fut, nem toboroz
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
NCT06985147· 2. fázis· Disc Medicine, Inc· Forrás
Toboroz
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
NCT06858397· 1/2. fázis· GC Biopharma Corp· Forrás
Toboroz
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors
NCT06827613· 1/2. fázis· Marengo Therapeutics, Inc.· Forrás
Fut, nem toboroz
A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy
NCT06848231· 2. fázis· Dasher Neuroscience Inc.· Forrás
Toboroz
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
NCT06072781· 3. fázis· Verastem, Inc.· Forrás
Toboroz
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
NCT04875702· 4. fázis· Massachusetts General Hospital· Forrás
Toboroz
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
NCT05970497· 1/2. fázis· Krystal Biotech, Inc.· Forrás
Toboroz
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
NCT05836987· 3. fázis· Johns Hopkins University· Forrás
Toboroz
Treatment of Refractory Infantile Spasms With Fenfluramine
NCT04289467· 2. fázis· Children's Hospital of Orange County· Forrás
Toboroz
Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.
NCT05419726· University of California, Los Angeles· Forrás
Fut, nem toboroz
The DISCOVER INOCA Prospective Multi-center Registry
NCT05288361· Yale University· Forrás
Fut, nem toboroz
A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)
NCT05031780· 2/3. fázis· Agios Pharmaceuticals, Inc.· Forrás
Toboroz
Pancreatic Cancer Early Detection Consortium
NCT04970056· Arbor Research Collaborative for Health· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Tüdőrák2 toboroz
Áttétes emlőrák1 toboroz
Elhízás1 toboroz
Fabry-betegség1 toboroz
Gaucher-kór1 toboroz
Gout1 toboroz
Gyomor- és nyelőcsőrák1 toboroz
Hasnyálmirigyrák1 toboroz
Melanóma1 toboroz
Petefészekrák1 toboroz
Pitvarfibrilláció1 toboroz
Stroke (szélütés)1 toboroz

Lezárt vizsgálatok

Toboroz
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
NCT06612268· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
NCT05641896· 2. fázis· SOFIE· Forrás
Lezárult
Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE
NCT05001737· 3. fázis· Swedish Orphan Biovitrum· Forrás
Lezárult
Allergic Disease Onset Prevention Study
NCT05003804· 1/2. fázis· Siolta Therapeutics, Inc.· Forrás
Leállították
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
NCT04100135· W.L.Gore & Associates· Forrás
Lezárult
DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)
NCT04014075· 2. fázis· Daiichi Sankyo· Forrás

Regiszterbeli névváltozatok (6)

A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.

UCLA Health
Los Angeles, California 90095
18 vizsgálat
UCLA Health
Santa Monica, California 90404
2 vizsgálat
- NCT04875702Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
  Contact: John Fitzgerald, MD, PhD
- NCT04014075DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)
University of California Los Angeles (UCLA) Health
Los Angeles, California 90095
2 vizsgálat
- NCT05836987The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
  Contact: Monserrath Campos
- NCT05641896Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
David Geffen School of Medicine UCLA, UCLA Health
Los Angeles, California 90095
1 vizsgálat
- NCT06858397A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
  Contact: Anjay Rastogi, MD (principal investigator)
UCLA DGSOM, UCLA Health, UCLA Semel Institute
Los Angeles, California 90095
1 vizsgálat
- NCT07184619Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
  Contact: Newron Pharmaceuticals
UCLA Health - Santa Monica Cancer Care
Los Angeles, California 90095
1 vizsgálat
- NCT07566052A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
  Contact: Astellas Pharma Global Development, Inc.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

Áttétes emlőrák13 munka · 1 vizsgálat

Intézményadatok: ROR 01d88se56 (CC0-1.0)Frissítve: 2026. nov. 10.

Hibát jelzek